A Conversation Between Stefano Buono and Ken Herrmann
J Nucl Med
.
2019 Dec;60(12):1659-1662.
doi: 10.2967/jnumed.119.238212.
Authors
Stefano Buono
1
,
Ken Herrmann
2
Affiliations
1
Elysia Capital LTD, London, UK; and.
2
Universitätsklinikum Essen, Essen, Germany.
PMID:
31792127
DOI:
10.2967/jnumed.119.238212
No abstract available
Publication types
Interview
MeSH terms
Diagnostic Imaging
Drug Industry
Nuclear Medicine*
Radiopharmaceuticals*
Substances
Radiopharmaceuticals